NASDAQ : MXCT
MaxCyte, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.73 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 178.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
MaxCyte, Inc. (MXCT) reported revenue of 31.05M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 31.05M | 33.03M | 38.63M | 41.29M | 44.26M | 33.89M |
| Cost of Revenue | 6.45M | 6.22M | 7.10M | 4.74M | 5.10M | 3.65M |
| Gross Profit | 24.60M | 26.80M | 31.53M | 36.55M | 39.16M | 30.25M |
| Selling, General & Admin | 38.22M | 46.29M | 56.19M | 57.04M | 44.48M | 31.68M |
| Research & Development | 16.76M | 20.82M | 22.23M | 23.82M | 19.51M | 15.41M |
| Operating Expenses | 59.03M | 71.34M | 82.56M | 84.84M | 66.52M | 48.44M |
| Operating Income | -34.43M | -44.53M | -51.03M | -48.30M | -27.36M | -18.19M |
| Interest Expense | -399.00K | |||||
| Interest & Investment Income | 6.16M | 7.27M | 10.14M | 10.38M | 3.92M | 150.80K |
| Other Non Operating Income (Expenses) | -127.00K | -645.40K | ||||
| EBT Excluding Unusual Items | -28.27M | -37.27M | -40.89M | -37.92M | -23.57M | -19.08M |
| Merger & Restructuring Charges | -3.81M | -3.81M | -164.00K | |||
| Impairment of Goodwill | -3.55M | -3.55M | ||||
| Pretax Income | -35.64M | -44.63M | -41.05M | -37.92M | -23.57M | -19.08M |
| Net Income | -35.64M | -44.63M | -41.05M | -37.92M | -23.57M | -19.08M |
| Net Income to Common | -35.64M | -44.63M | -41.05M | -37.92M | -23.57M | -19.08M |
| Shares Outstanding (Basic) | 106.76M | 106.43M | 104.85M | 103.27M | 101.70M | 90.62M |
| Shares Outstanding (Diluted) | 106.76M | 106.43M | 104.85M | 103.27M | 101.70M | 90.62M |
| EPS (Basic) | -0.33 | -0.42 | -0.39 | -0.37 | -0.23 | -0.21 |
| EPS (Diluted) | -0.33 | -0.42 | -0.39 | -0.37 | -0.23 | -0.21 |
| Free Cash Flow | -23.64M | -36.18M | -29.26M | -25.39M | -33.26M | -14.51M |
| Free Cash Flow Per Share | -0.22 | -0.34 | -0.28 | -0.25 | -0.33 | -0.16 |
| Gross Margin | 79.23% | 81.16% | 81.62% | 88.52% | 88.48% | 89.24% |
| Operating Margin | -110.88% | -134.84% | -132.12% | -116.98% | -61.82% | -53.66% |
| Profit Margin | -114.77% | -135.14% | -106.29% | -91.85% | -53.25% | -56.30% |
| Free Cash Flow Margin | -76.14% | -109.54% | -75.75% | -61.48% | -75.14% | -42.82% |
| EBITDA | -30.29M | -40.22M | -46.72M | -44.13M | -24.66M | -16.76M |
| EBITDA Margin | -97.54% | -121.79% | -120.95% | -106.88% | -55.72% | -49.46% |
| D&A For EBITDA | 4.14M | 4.31M | 4.32M | 4.17M | 2.70M | 1.42M |
| EBIT | -34.43M | -44.53M | -51.03M | -48.30M | -27.36M | -18.19M |
| EBIT Margin | -110.88% | -134.84% | -132.12% | -116.98% | -61.82% | -53.66% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 15.04M | 20.07M | 27.88M | 46.51M | 11.06M | 47.78M |
| Short-Term Investments | 90.65M | 82.98M | 126.60M | 121.78M | 216.28M | 207.26M |
| Cash & Short-Term Investments | 105.69M | 103.04M | 154.48M | 168.29M | 227.34M | 255.04M |
| Accounts Receivable | 3.92M | 3.50M | 4.68M | 5.78M | 11.18M | 6.88M |
| Other Receivables | 1.91M | |||||
| Receivables | 3.92M | 3.50M | 4.68M | 5.78M | 13.09M | 6.88M |
| Inventory | 7.80M | 7.55M | 8.91M | 12.23M | 8.58M | 5.20M |
| Prepaid Expenses | 3.66M | 4.28M | 3.61M | 3.90M | 3.26M | 3.31M |
| Other Current Assets | 200.00K | |||||
| Total Current Assets | 121.27M | 118.37M | 171.68M | 190.19M | 252.27M | 270.43M |
| Property, Plant & Equipment | 25.37M | 28.45M | 30.47M | 34.75M | 33.58M | 13.37M |
| Long-Term Investments | 36.23M | 52.57M | 35.78M | 42.94M | ||
| Other Intangible Assets | 766.00K | 650.00K | ||||
| Other Long-Term Assets | 1.03M | 2.47M | 1.53M | 388.00K | 809.00K | 316.70K |
| Total Assets | 184.67M | 202.51M | 239.47M | 268.27M | 286.65M | 284.12M |
| Accounts Payable | 1.73M | 1.40M | 1.36M | 743.00K | 292.00K | 1.82M |
| Accrued Expenses | 4.17M | 7.81M | 8.30M | 11.27M | 8.27M | 6.52M |
| Current Portion of Leases | 1.53M | 1.46M | 864.00K | 774.00K | 157.00K | 527.20K |
| Current Unearned Revenue | 2.46M | 3.60M | 5.25M | 5.07M | 6.71M | 6.75M |
| Total Current Liabilities | 9.89M | 14.27M | 15.78M | 17.86M | 15.43M | 15.62M |
| Long-Term Leases | 15.72M | 16.49M | 17.17M | 17.97M | 15.94M | 5.15M |
| Other Long-Term Liabilities | 302.00K | 263.00K | 274.00K | 283.00K | 1.32M | 450.20K |
| Total Liabilities | 25.92M | 31.02M | 33.22M | 36.11M | 32.69M | 21.22M |
| Common Stock | 1.07M | 1.07M | 1.06M | 1.04M | 1.02M | 1.01M |
| Additional Paid-In Capital | 434.26M | 431.90M | 422.05M | 406.93M | 390.82M | 376.19M |
| Retained Earnings | -275.11M | -261.48M | -216.85M | -175.80M | -137.88M | -114.30M |
| Total Common Equity | 158.75M | 171.49M | 206.25M | 232.17M | 253.97M | 262.90M |
| Shareholders' Equity | 158.75M | 171.49M | 206.25M | 232.17M | 253.97M | 262.90M |
| Total Liabilities & Equity | 184.67M | 202.51M | 239.47M | 268.27M | 286.65M | 284.12M |
| Total Debt | 17.25M | 17.94M | 18.03M | 18.74M | 16.09M | 5.68M |
| Net Cash (Debt) | 88.44M | 85.10M | 136.45M | 149.54M | 211.25M | 249.36M |
| Net Cash Per Share | 0.83 | 0.80 | 1.30 | 1.45 | 2.08 | 2.75 |
| Filing Date Shares Outstanding | 103.21M | 106.86M | 106.03M | 104.13M | 102.90M | 101.51M |
| Total Common Shares Outstanding | 106.13M | 106.79M | 105.71M | 103.96M | 102.40M | 101.20M |
| Working Capital | 111.38M | 104.10M | 155.91M | 172.34M | 236.84M | 254.81M |
| Book Value Per Share | 1.50 | 1.61 | 1.95 | 2.23 | 2.48 | 2.60 |
| Tangible Book Value | 157.99M | 170.84M | 206.25M | 232.17M | 253.97M | 262.90M |
| Tangible Book Value Per Share | 1.49 | 1.60 | 1.95 | 2.23 | 2.48 | 2.60 |
| Machinery | 11.99M | 14.46M | 13.95M | 14.73M | 11.96M | 8.12M |
| Construction In Progress | 15.00K | 908.00K | 272.00K | 310.00K | 627.00K | 1.16M |
| Leasehold Improvements | 14.79M | 14.79M | 14.73M | 14.65M | 14.20M | 641.40K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -35.64M | -44.63M | -41.05M | -37.92M | -23.57M | -19.08M |
| Depreciation & Amortization | 5.01M | 5.11M | 4.79M | 4.57M | 2.70M | 1.42M |
| Other Amortization | 28.00K | 28.00K | ||||
| Loss (Gain) From Sale of Assets | 326.00K | 370.00K | 924.00K | 124.00K | 215.00K | 84.10K |
| Asset Writedown & Restructuring Costs | 4.18M | 3.55M | ||||
| Loss (Gain) From Sale of Investments | -1.85M | -2.65M | -6.24M | -7.12M | -2.67M | -70.30K |
| Stock-Based Compensation | 4.96M | 9.21M | 13.08M | 13.98M | 11.75M | 7.96M |
| Provision & Write-off of Bad Debts | 25.00K | 35.00K | -130.00K | 171.00K | ||
| Other Operating Activities | 890.00K | 676.00K | 1.77M | 697.00K | 767.00K | 650.80K |
| Change in Accounts Receivable | 1.81M | 1.15M | 1.23M | 7.14M | -6.48M | -1.71M |
| Change in Inventory | -1.03M | 575.00K | 1.36M | -4.53M | -3.49M | -1.41M |
| Change in Accounts Payable | -1.66M | -3.72M | -1.88M | 3.25M | -150.00K | 2.09M |
| Change in Unearned Revenue | 18.00K | -1.68M | 182.00K | -1.64M | -34.00K | 1.90M |
| Change in Other Net Operating Assets | -55.00K | -2.45M | -1.64M | -392.00K | 6.18M | -2.53M |
| Operating Cash Flow | -22.98M | -34.41M | -27.61M | -21.69M | -14.78M | -10.68M |
| Capital Expenditures | -665.00K | -1.77M | -1.65M | -3.70M | -18.48M | -3.83M |
| Sale of Property, Plant & Equipment | 9.00K | 4.60K | ||||
| Cash Acquisitions | -1.77M | |||||
| Investment in Securities | 24.91M | 29.48M | 8.58M | 58.67M | -6.35M | -191.18M |
| Investing Cash Flow | 24.09M | 25.93M | 6.93M | 54.98M | -24.82M | -195.01M |
| Long-Term Debt Repaid | -4.99M | |||||
| Net Debt Issued (Repaid) | -4.99M | |||||
| Issuance of Common Stock | 182.00K | 656.00K | 2.06M | 2.14M | 2.89M | 239.71M |
| Financing Cash Flow | -1.30M | 656.00K | 2.06M | 2.14M | 2.89M | 234.72M |
| Net Cash Flow | -183.00K | -7.82M | -18.62M | 35.44M | -36.72M | 29.03M |
| Free Cash Flow | -23.64M | -36.18M | -29.26M | -25.39M | -33.26M | -14.51M |
| Free Cash Flow Margin | -76.14% | -109.54% | -75.75% | -61.48% | -75.14% | -42.82% |
| Free Cash Flow Per Share | -0.22 | -0.34 | -0.28 | -0.25 | -0.33 | -0.16 |
| Levered Free Cash Flow | -13.14M | -15.47M | -13.14M | -10.51M | -30.49M | -6.82M |
| Unlevered Free Cash Flow | -13.14M | -15.47M | -13.14M | -10.51M | -30.49M | -6.57M |
| Cash Interest Paid | 420.90K | |||||
| Change in Working Capital | -919.00K | -6.12M | -751.00K | 3.82M | -3.98M | -1.64M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 149.65M | 165.34M | 439.69M | 488.14M | 558.17M | 1.03B |
| Enterprise Value | 61.21M | 77.78M | 304.17M | 313.98M | 340.31M | 776.44M |
| Last Close Price | 1.45 | 1.55 | 4.16 | 4.70 | 5.46 | 10.19 |
| PS Ratio | 4.82 | 5.01 | 11.38 | 11.82 | 12.61 | 30.43 |
| PB Ratio | 0.97 | 0.96 | 2.13 | 2.10 | 2.20 | 3.92 |
| P/TBV Ratio | 0.95 | 0.97 | 2.13 | 2.10 | 2.20 | 3.92 |
| EV/Sales Ratio | 1.97 | 2.35 | 7.88 | 7.61 | 7.69 | 22.91 |
| Debt / Equity Ratio | 0.11 | 0.10 | 0.09 | 0.08 | 0.06 | 0.02 |
| Net Debt / Equity Ratio | -0.56 | -0.50 | -0.66 | -0.64 | -0.83 | -0.95 |
| Net Debt / EBITDA Ratio | 2.92 | 2.12 | 2.92 | 3.39 | 8.56 | 14.87 |
| Net Debt / FCF Ratio | 3.74 | 2.35 | 4.66 | 5.89 | 6.35 | 17.18 |
| Asset Turnover | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.20 |
| Inventory Turnover | 0.82 | 0.76 | 0.67 | 0.46 | 0.74 | 0.77 |
| Quick Ratio | 11.08 | 7.47 | 10.09 | 9.75 | 15.59 | 16.77 |
| Current Ratio | 12.26 | 8.30 | 10.88 | 10.65 | 16.35 | 17.32 |
| Return on Equity (ROE) | -20.39% | -23.63% | -18.73% | -15.60% | -9.12% | -12.89% |
| Return on Assets (ROA) | -10.64% | -12.60% | -12.56% | -10.88% | -5.99% | -6.77% |
| Return on Capital Employed (ROCE) | -19.70% | -23.70% | -22.80% | -19.30% | -10.10% | -6.80% |
| Earnings Yield | -23.02% | -26.99% | -9.34% | -7.77% | -4.22% | -1.85% |
| FCF Yield | -15.80% | -21.88% | -6.65% | -5.20% | -5.96% | -1.41% |
| Buyback Yield / Dilution | -0.95% | -1.51% | -1.53% | -1.54% | -12.23% | -30.45% |